Cargando…
Angiogenesis: A Pivotal Therapeutic Target in the Drug Development of Gynecologic Cancers
SIMPLE SUMMARY: Angiogenesis, defined as the abnormal development of new blood vessels in cancer, is a key component of cancer development. Clinical trials have proven that angiogenesis blockers can be effective in halting cancer growth across numerous types of gynecologic cancers. This review discu...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908988/ https://www.ncbi.nlm.nih.gov/pubmed/35267430 http://dx.doi.org/10.3390/cancers14051122 |